Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹1,125 Cr
up ₹26.2 Cr vs Jun 2025
- Stocks held
- 42
- up 2 vs Jun 2025
- Top 10 weight
- 47.5%
- of the portfolio in its ten largest
- Cash & debt
- 1.9%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 22
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In October 2025 it disclosed 42 stocks worth ₹1,125 Cr, up ₹26.2 Cr from Jun 2025. Its largest positions were Sun Pharmaceutical Industries Limited (9.8%), Ajanta Pharma Limited (6.2%), Lupin Limited (5.6%); the ten largest together made up 47.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.7% of its equity. Cash and debt stood at 1.9%. Compared with Jun 2025 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
53%
Top-10 weight is higher than 53% of peers
Breadth
46%
Holds more stocks than 46% of peers
Cash
29%
Holds more cash than 29% of peers
Holdings in October 2025
Download CSVEvery line the fund disclosed, with the change against Jun 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 9.77%
- Δ weight
- down 0.31 pts
- Value
- ₹110 Cr
- Δ value
- down ₹87 L
- Status
- Trimmed
- Weight
- 6.25%
- Δ weight
- up 1.33 pts
- Value
- ₹70.3 Cr
- Δ value
- up ₹16.2 Cr
- Status
- Added
- Weight
- 5.58%
- Δ weight
- up 2.05 pts
- Value
- ₹62.7 Cr
- Δ value
- up ₹24 Cr
- Status
- Added
- Weight
- 4.12%
- Δ weight
- up 0.13 pts
- Value
- ₹46.3 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 3.74%
- Δ weight
- down 1.75 pts
- Value
- ₹42 Cr
- Δ value
- down ₹18.2 Cr
- Status
- Trimmed
- Weight
- 3.67%
- Δ weight
- down 0.62 pts
- Value
- ₹41.3 Cr
- Δ value
- down ₹5.9 Cr
- Status
- Trimmed
- Weight
- 3.65%
- Δ weight
- up 0.65 pts
- Value
- ₹41.1 Cr
- Δ value
- up ₹8.1 Cr
- Status
- Added
- Weight
- 3.62%
- Δ weight
- up 0.13 pts
- Value
- ₹40.7 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 3.57%
- Δ weight
- down 0.64 pts
- Value
- ₹40.1 Cr
- Δ value
- down ₹6.1 Cr
- Status
- Trimmed
- Weight
- 3.52%
- Δ weight
- up 1.41 pts
- Value
- ₹39.6 Cr
- Δ value
- up ₹16.4 Cr
- Status
- Added
- Weight
- 3.20%
- Δ weight
- up 0.14 pts
- Value
- ₹36.1 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 2.99%
- Δ weight
- down 0.48 pts
- Value
- ₹33.7 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 2.55%
- Δ weight
- down 0.82 pts
- Value
- ₹28.6 Cr
- Δ value
- down ₹8.3 Cr
- Status
- Trimmed
- Weight
- 2.54%
- Δ weight
- down 0.21 pts
- Value
- ₹28.5 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 2.53%
- Δ weight
- down 0.05 pts
- Value
- ₹28.5 Cr
- Δ value
- up ₹10 L
- Status
- Held
- Weight
- 2.45%
- Δ weight
- down 0.34 pts
- Value
- ₹27.5 Cr
- Δ value
- down ₹3.1 Cr
- Status
- Trimmed
- Weight
- 2.41%
- Δ weight
- down 0.39 pts
- Value
- ₹27.1 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 2.36%
- Δ weight
- down 0.37 pts
- Value
- ₹26.6 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 2.26%
- Δ weight
- down 0.37 pts
- Value
- ₹25.5 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.88%
- Δ weight
- up 0.78 pts
- Value
- ₹21.1 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Weight
- 1.87%
- Δ weight
- up 0.10 pts
- Value
- ₹21.1 Cr
- Δ value
- up ₹1.5 Cr
- Status
- Added
- Weight
- 1.84%
- Δ weight
- down 0.25 pts
- Value
- ₹20.7 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 1.79%
- Δ weight
- up 0.27 pts
- Value
- ₹20.1 Cr
- Δ value
- up ₹3.4 Cr
- Status
- Added
- Weight
- 1.78%
- Δ weight
- down 0.17 pts
- Value
- ₹20 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 1.73%
- Δ weight
- up 0.12 pts
- Value
- ₹19.4 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 1.69%
- Δ weight
- up 0.14 pts
- Value
- ₹19.1 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 1.66%
- Δ weight
- up 0.13 pts
- Value
- ₹18.7 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 1.58%
- Δ weight
- up 1.58 pts
- Value
- ₹17.8 Cr
- Δ value
- up ₹17.8 Cr
- Status
- New
- Weight
- 1.35%
- Δ weight
- up 0.05 pts
- Value
- ₹15.2 Cr
- Δ value
- up ₹88 L
- Status
- Added
- Weight
- 1.22%
- Δ weight
- down 0.57 pts
- Value
- ₹13.7 Cr
- Δ value
- down ₹6 Cr
- Status
- Trimmed
- Weight
- 1.08%
- Δ weight
- up 0.15 pts
- Value
- ₹12.1 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 1.05%
- Δ weight
- down 0.20 pts
- Value
- ₹11.9 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 1.04%
- Δ weight
- down 0.19 pts
- Value
- ₹11.7 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 1.04%
- Δ weight
- down 0.01 pts
- Value
- ₹11.7 Cr
- Δ value
- up ₹20 L
- Status
- Added
- Weight
- 0.99%
- Δ weight
- down 0.23 pts
- Value
- ₹11.2 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 0.96%
- Δ weight
- down 0.22 pts
- Value
- ₹10.8 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 0.95%
- Δ weight
- down 0.23 pts
- Value
- ₹10.7 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 0.88%
- Δ weight
- up 0.06 pts
- Value
- ₹9.9 Cr
- Δ value
- up ₹84 L
- Status
- Added
- Weight
- 0.88%
- Δ weight
- down 0.11 pts
- Value
- ₹9.9 Cr
- Δ value
- down ₹98 L
- Status
- Trimmed
- Weight
- 0.87%
- Δ weight
- down 0.16 pts
- Value
- ₹9.8 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 0.65%
- Δ weight
- down <0.01 pts
- Value
- ₹7.3 Cr
- Δ value
- up ₹12 L
- Status
- Added
- Weight
- 0.43%
- Δ weight
- down 0.51 pts
- Value
- ₹4.8 Cr
- Δ value
- down ₹5.4 Cr
- Status
- Trimmed
- Weight
- 0.01%
- Δ weight
- up 0.01 pts
- Value
- ₹14 L
- Δ value
- up ₹14 L
- Status
- New
What changed, Jun 2025 to Oct 2025
New New positions (2)
- Anthem Biosciences Limited1.6% · ₹17.8 Cr
- Dr. Lal Path Labs Limited<0.1% · ₹14 L
Exited Exited (0)
None.
Added Biggest additions
- Lupin Limitedup ₹24 Cr (+2.05% pts)
- Alkem Laboratories Limitedup ₹16.4 Cr (+1.41% pts)
- Ajanta Pharma Limitedup ₹16.2 Cr (+1.33% pts)
- Gland Pharma Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2025, the weight rose most in Pharmaceuticals & Biotechnology (+2.0 pts), and fell most in Healthcare Services (−1.5 pts) and Healthcare Equipment & Supplies (−0.5 pts).
- Pharmaceuticals & Biotechnology74.7% → 76.7%+2.0 pts
- Healthcare Services24.3% → 22.8%−1.5 pts
- Healthcare Equipment & Supplies0.9% → 0.4%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2022 | Oct 2024 | Apr 2025 | Jun 2025 | Jun 2025 | Oct 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.0% | 76.5% | 75.3% | 74.7% | 74.7% | 76.7% |
| Healthcare Services | 18.3% | 21.6% | 23.1% | 24.3% | 24.3% | 22.8% |
| Healthcare Equipment & Supplies | 1.7% | 0.9% | 1.6% | 0.9% | 0.9% | 0.4% |
Allocation in Oct 2025change vs Jun 2025
- Pharmaceuticals & Biotechnology (29)76.7%▲ 2.0 pts
- Healthcare Services (12)22.8%▼ 1.5 pts
- Healthcare Equipment & Supplies (1)0.4%▼ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2025
1.9%
▲ 0.8 pts vs Jun 2025
- Cash alone
- 1.9%
- cash and net receivables
- A year earlier
- 1.5%
- Oct 2024 · now ▲ 0.4 pts
- Last 12 months
- 0.4% – 2.4%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.